Close
STAR Immunotherapy Study
- About Us
-
Cancer Care
-
Our Cancer Programs
- Adolescent and Young Adult Cancer Program
- Blood Cancer & Hematological Malignancy Program
- Blood Disorder (Hematology) Program
- Breast Cancer Program
- Cancer Risk Reduction and Education Clinic
- Cardio-Oncology Program
- Cancer Genetics Program
- Childhood Cancer Survivorship Program
- Endocrine Tumor Program
- Eye Cancer Program
- Gastrointestinal (GI) Cancer Program
- Genitourinary Cancer Program
- Gynecologic Oncology Program
- Head and Neck Cancer Program
- Liver Tumor and Cancer Program
- Lung Cancer Program
- Neuro-Oncology (Brain Tumor) Program
- Neurofibromatosis Program
- Pediatric Neuro-Oncology Program
- Pediatric Oncology Program
- Pediatric Sarcoma Program
- Pediatric Thrombosis Program
- Radiation Oncology
- Sarcoma Cancer Program
- Skin Cancer Program
- Supportive Cancer Care Program
-
Screening and Diagnosis
- Cervical Cancer Screening Guidelines
- Colorectal Cancer Screening
- Endometrial (Uterine) Cancer Screening Guidelines
- Hepatitis and Cancer
- HPV Vaccine and Screenings
- Liver Cancer Guidelines
- Lung Cancer Screening
- Mammogram
- Ovarian Cancer Screening Guidelines
- Prostate Cancer Screening Guidelines
- Skin Cancer Screenings
- Sun and Skin Safety
- Tobacco Use and Cancer
- Skin Cancer Screenings
- Cancer Genetics Program
- Cancer Survivorship Program
- Cancer Treatments
- Conditions
-
Our Cancer Programs
- Clinical Trials and Research
- Donate and Volunteer
- Education
- Patients and Families
- Appointments
- Doctors and Locations
-
Community Outreach and Engagement Program
- Message from COE Leadership
- South Texas Cancer Burden and COE Areas of Work
- Our COE Impact
- COE Community Advisory Board
- COE Publications
- Avanzando Caminos (Leading Pathways) Study
- Estudio Avanzando Caminos (Leading Pathways)
- San Antonio Firefighters Cancer Prevention Program
- STAR Immunotherapy Study
Our team wants to hear about your experience (including side effects and symptoms) so that we can provide better support to patients in the future.
The goal of this study is to better understand how immunotherapy affects your quality of life through detailed assessments of your side effects and symptoms. You would be asked to complete questionnaires (remotely or in-person) once a month for a year and a half.
The STAR Immunotherapy Study is an observational study that will enroll 416 stage IV patients in South Texas and South Florida.
This study is funded by the National Cancer Institute.
You can receive up to $950 in payment for participation!
Who Can Join
To enroll, you must meet the following criteria:
- Be 18 years or older
- Speak English or Spanish
- Have a medical chart confirmed diagnosis of stage IV melanoma, lung, kidney, breast, colorectal, or bladder cancer
- Be initiating treatment with an immune checkpoint inhibitor (ICI) alone or in combination with other cancer therapy
- Have no previous treatment exposure to an ICI
- Willing to complete nineteen surveys—one at the baseline visit and one each month for 18 months.
San Antonio
If you are interested in the STAR Study or getting in touch with us, please fill out the form below or email us at STARstudy@uthscsa.edu or contact the office at 210-562-6508.
Miami
If you are interested in the STAR Study or getting in touch with us, please fill out the form above or email us at STARstudy@miami.edu or contact the office at 305-243-7878.
